Go phase 1 Go Happening right now! *** Cardiol's phase 1 clinical trial is a double-blind, placebo-controlled, randomized study to assess safety, tolerability and pharmacokinetics of single followed by multiple-day ascending doses of CardiolRx administered orally in up to 55 healthy adult subjects, both in the fasting and fed states.